• Events
0 Items
Patients Rising Now
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate
Select Page
  • Home
  • About
    • About Us
    • Who We Are
    • Partners and Coalitions
    • Corporate Members
    • Financials
  • News & Insights
  • Positions & Resources
    • Legislative Policy Positions
    • State Actions & Resources
    • Policy Supported
  • Take Action
    • Take Action
    • We The Patients
    • Events
  • Donate

Medicare Part D

Wilcox Statement on HHS Medicare Part D Affordability Report

Wilcox Statement on HHS Medicare Part D Affordability Report

Jan 20, 2022 | Featured, Medicare Part D, Statements

WASHINGTON — Patients Rising Executive Director Terry Wilcox today released the following statement regarding the Department of Health and Human Services’ new report on prescription drug affordability for Medicare Part D patients: “Action must be taken to make...
Read more
H.R.3 and H.R.19: Tougher Rules to Reduce Drug Prices and Patient Spending

H.R.3 and H.R.19: Tougher Rules to Reduce Drug Prices and Patient Spending

May 25, 2021 | Federal Issues, Medicare Part D

By Surabhi Dangi-Garimella, PhD Opinions vary on the impact H.R.3 would have on patients and the U.S. health care system as a whole, depending on who you ask. Some of the changes proposed by H.R.3 are directed to redesign the Medicare Part D prescription drug...
Read more
Wilcox Statement on HHS Medicare Part D Affordability Report

New Government, Revised Rules? Seniors and Prescription Drug Cost-Sharing

Jan 20, 2021 | Featured, Medicare Part D

By Surabhi Dangi-Garimella, Ph.D. Prescription drugs can be expensive, and for patients undergoing treatment for certain chronic conditions, cost-sharing is a heavy financial burden, especially if you are a Medicare beneficiary on a fixed income. While bills...
Read more

A Healthcare Win for Congress: Stop the Medicare Part D Out-of-Pocket Cliff

Nov 19, 2019 | Medicare Part D, Op-Ed

By Terry Wilcox Executive Director, Patients Rising Better health care was the top concern for 41 percent of voters in the midterm elections but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the...
Read more

Will Divided Government Produce Lower Drug Prices?

Aug 6, 2019 | Drug Costs, Medicare Part D, News

Divided government, as a result of Democrats taking back the House of Representatives in last week’s election, means that almost all legislation will grind to a halt. This is especially true in today’s era of political polarization. But there is one Democratic policy...
Read more

A Health Care Win for Congress: Stop the Medicare Part D Out-of-Pocket Cliff

Aug 6, 2019 | Medicare Part D, News

Better health care was the top concern for 41 percent of voters in the midterm elections, but Congress does not have to wait until next year to pass bipartisan health legislation. Among the must-pass bills for the 2018 lame duck session should be legislation that...
Read more
« Older Entries

Categories

  • Access
  • Advocacy
  • California
  • Coalitions
  • Comment Letters
  • Copay Accumulators
  • Copay Assistance
  • COVID-19
  • Drug Costs
  • Event
  • FDA
  • Featured
  • Featured Action
  • Federal Issues
  • Health Insurance
  • Health Policy
  • ICER
  • Illinois
  • Issues
  • Letters Submitted
  • Letters Supported
  • Massachusetts
  • Medicaid
  • Medicare
  • Medicare Part D
  • News
  • Op-Ed
  • Out of Pocket Costs
  • Pharmacy Benefit Managers
  • Podcast
  • Policy Supported
  • Prescription Drugs
  • Press Releases
  • Public Statement
  • QALY
  • State Issues
  • Statements
  • Step Therapy
  • Surprise Billing
  • Uncategorized
  • Value Based Insurance Design
  • Value Frameworks
  • Virtual Advocacy Chat

Tags

21st Century Cures Act 340B Access to Care Advocacy Alzheimer's Biden Administration biosimilars Cancer cms Copay Accumulators copay assistance COVID-19 Vaccine drug costs Drug Manufacturing Drug Pricing drug rebate fail first FDA Gene Therapies H.R.3 Health Insurance hospital bills HR 3708 hsa ICER Insurance design Joe Biden medicare Part B medicare part D Mental Health Nonmedical Switching open enrollment Out of Pocket Costs PBM PBMs pharmacy benefit managers Price Transparency Prior Authorization QALY Rare Disease Right to Repair Step Therapy Telehealth transparency Value Framework

Recent Posts

  • National Patient Group: White House’s War on Patients Harms Sick Americans
  • Letter to Senate Leadership Supporting PBM Reform from Employers & Other Stakeholders
  • Patients Rising Now Statement: ICER’s ‘Updates’ are Thinly Veiled Strategy to Continue Discriminatory Tactics
  • Patients Rising Now Issues Statement on E&C IRA Hearing
  • Patients Rising Now Signs onto Letter to Increase Patient Access to Pharmacy Services

Get Updates In Your Inbox

Sign up for updates about our patient education, support and advocacy programs and initiatives.

YES, KEEP ME UPDATED

Patients Rising Now

We are a 501c4 group dedicated to demanding transparency in health care.  We are part of the Patients Rising suite of programs and services.

700 12th St. NW 700, Suite 700
Washington, DC 20005
202-679-8223

 

  • Privacy Policy
  • Sponsor Opportunities
  • Patients Rising
  • Events
  • We The Patients
  • Facebook
  • X
  • Instagram
All rights reserved. © 2023 Patients Rising Now